ICON lifts its 2025 revenue forecast, beats booking targets in Q2 and expands its share buyback plan as market conditions remain variable.

Q2 2025 Management View CEO Steven A. Cutler highlighted an 11% sequential increase in gross business awards over quarter 1, driven by wins from biotech customers and ongoing expansion in large pharma ...

Gross business wins in the quarter of $2,966 million, representing an increase of 10.6% on quarter one 2025. Net business ...